Pernicious anemia affects roughly 0.1% of the general population and up to 2% of people over age 60, making it uncommon but far from rare. It is the most common cause of vitamin B12 deficiency worldwide, and because its symptoms develop slowly, many cases go undiagnosed for years. Understanding how often it occurs, who is most likely to develop it, and what makes it difficult to catch can help you recognize it earlier.
How Common Is Pernicious Anemia?
Population studies estimate that pernicious anemia occurs in about 1 in 1,000 people overall. That number climbs significantly with age. Among adults over 60, prevalence reaches roughly 1 to 2 in 100, partly because the autoimmune process that causes the condition has had decades to damage the stomach lining. In nursing home populations, estimates run even higher because routine screening is uncommon and mild cases often get attributed to aging.
People of Northern European descent, particularly those with Scandinavian or British ancestry, have historically shown the highest rates. African Americans also appear to develop pernicious anemia at elevated rates compared to the general U.S. population, and the condition tends to appear at a younger average age in Black women. Latin American and Asian populations have lower documented rates, though underdiagnosis in these groups likely plays a role.
Women are diagnosed more often than men, at a ratio of roughly 1.5 to 1. The typical age at diagnosis is around 60, but pernicious anemia can appear at any age, including in children and young adults with a strong family history of autoimmune disease.
Why It Often Goes Undetected
The true prevalence of pernicious anemia is almost certainly higher than reported figures suggest. The condition develops gradually as the immune system destroys cells in the stomach lining that produce a protein called intrinsic factor. Without intrinsic factor, you can’t absorb B12 from food, but your body stores enough B12 to last three to five years. That long runway means symptoms creep in so slowly that many people and their doctors attribute the fatigue, brain fog, or tingling in the hands and feet to stress, aging, or other conditions.
Diagnosis also depends on blood tests that aren’t part of standard checkups. The most specific test looks for antibodies that block intrinsic factor, but these antibodies only show up in about 60% of people who actually have pernicious anemia. A second test checks for antibodies against the stomach’s acid-producing cells, which are present in about 90% of patients but also appear in other conditions, making that test less precise on its own. This means a negative antibody test doesn’t rule out the disease, and some people never receive a definitive diagnosis even when they clearly have it.
Who Is Most at Risk
Pernicious anemia is an autoimmune disease, and like most autoimmune conditions, it clusters with others. Up to 50% of people with pernicious anemia also test positive for antibodies associated with Hashimoto’s thyroiditis, the most common cause of underactive thyroid. The condition also shows a strong link with type 1 diabetes, vitiligo, and Addison’s disease. If you already have one autoimmune condition, your risk of developing pernicious anemia is meaningfully higher than the general population’s.
Family history matters too. First-degree relatives of someone with pernicious anemia have an increased risk, suggesting a genetic component that affects how the immune system targets the stomach lining. Some researchers estimate the risk among close relatives is five to ten times that of the general population, though exact numbers vary across studies.
Age is the single biggest risk factor aside from autoimmune history. The stomach lining thins naturally over time, and the autoimmune destruction that causes pernicious anemia accelerates that process. By the time symptoms appear, the damage is usually extensive and irreversible, which is why treatment is lifelong.
How Pernicious Anemia Differs From Other B12 Deficiency
Not all B12 deficiency is pernicious anemia. You can become deficient from a vegan or vegetarian diet, from medications that reduce stomach acid, or from conditions like Crohn’s disease that affect nutrient absorption. The difference is that pernicious anemia specifically involves autoimmune destruction of the stomach’s intrinsic factor system, which means oral B12 supplements at normal doses won’t fix the problem. Your gut simply can’t absorb the vitamin through the usual pathway.
This distinction matters for treatment. Standard dietary B12 deficiency responds to supplements you can take by mouth. Pernicious anemia typically requires B12 injections: a loading phase of weekly injections for the first month, followed by one injection per month for life. Some patients do well with very high-dose oral B12, which bypasses the normal absorption pathway through passive diffusion, but injections remain the standard approach. Most people notice improvement in energy and mental clarity within the first few weeks of treatment, though nerve damage from prolonged deficiency can take months to improve and may not fully reverse.
Symptoms That Should Prompt Testing
The early symptoms of pernicious anemia overlap with dozens of other conditions, which is part of why it gets missed. Persistent fatigue that doesn’t improve with sleep is the most common complaint. Other early signs include a sore, smooth tongue, pale or slightly yellow skin, and subtle changes in balance or coordination.
Neurological symptoms deserve particular attention because they can become permanent if B12 levels stay low long enough. These include numbness or tingling in the hands and feet, difficulty walking, memory problems, and mood changes including depression and irritability. In severe cases, untreated pernicious anemia can cause irreversible damage to the spinal cord.
If you have an existing autoimmune condition, a family history of pernicious anemia, or unexplained symptoms that match the pattern above, a simple blood test measuring your B12 level is a reasonable starting point. Levels below roughly 200 picograms per milliliter typically warrant further investigation, though some people develop symptoms at levels that fall within the low-normal range. A complete blood count showing unusually large red blood cells is another classic clue, though this finding isn’t always present early in the disease.